Finance | Sinopharm Holdings’ profit increased by 6% last year – Wealth Insights

The performance of Sinopharm Holdings (01099) last year was exciting. The company announced that it earned 6% more last year, and the profit attributable to shareholders reached 9.054 billion yuan, an increase of 619% year-on-year. This news gives investors confidence in Sinopharm's future.

Steady growth and continued improvement

Sinopharm Holdings' earnings per share reached 2.9 yuan, and it also announced a dividend. This shows that the company's business operations are growing steadily and are continuing to improve. Investors are optimistic about Sinopharm Holdings' long-term development prospects.

Actively expand the market and enhance competitiveness

Sinopharm Holdings has been committed to actively expanding the market and improving its competitiveness. The company has achieved good performance in the past year, which is due to the wise decision-making of the company's management and the hard work of the team.

Looking forward to the future, full of hope

Looking forward to the future, Sinopharm Holdings will continue to work hard to maintain steady growth in business performance and continuously improve its competitiveness. The company will continue to strive to create value for shareholders and achieve common interests.

Conclusion

Overall, Sinopharm's performance last year was satisfactory and the company continues to move forward on the path of steady growth. Investors have full confidence in the future of Sinopharm Holdings and believe that the company will achieve better results.